Evidence map›Paper›PMID 40978038›Full record

ArticleFrontiers in oncology2025

Role of the

Zhengran Sun, Ding Qi, Li Liu, Wenxia Ai, Buwei Han, Shimeng Wang, Mingge Liang, Yonggang Xia

Abstract read
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Zhengran SunHarbin Medical University, Harbin, Heilongjiang, China.
Ding QiHeilongjiang University Of Chinese Medicine, Harbin, Heilongjiang, China.
Li LiuHeilongjiang University Of Chinese Medicine, Harbin, Heilongjiang, China.
Wenxia AiThe 1st Affiliated Hospital of Heilongjiang University of Traditional Chinese Medicine, Harbin, Heilongjiang, China.
Buwei HanHarbin University of Commerce, Harbin, Heilongjiang, China.
Shimeng WangHeilongjiang University Of Chinese Medicine, Harbin, Heilongjiang, China.
Mingge LiangHeilongjiang University Of Chinese Medicine, Harbin, Heilongjiang, China.
Yonggang XiaHeilongjiang University Of Chinese Medicine, Harbin, Heilongjiang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: This study aimed to elucidate the molecular mechanisms underlying cervical precancerous lesions by employing bioinformatic approaches to identify key genes and signaling pathways. Methods: A comprehensive strategy was adopted, beginning with the analysis of GEO datasets to determine differentially expressed genes (DEGs) between cervical squamous intraepithelial lesions (CSILs) and normal cervical tissues. Protein-protein interaction (PPI) networks were constructed using STRING 11.0 and visualized with Cytoscape 3.7.2. Functional annotation through Gene Ontology (GO) and KEGG pathway enrichment using DAVID revealed biological processes, cellular components, molecular functions, and signaling pathways associated with the DEGs. Gene Set Enrichment Analysis (GSEA) further refined critical genes and enriched pathways. Similarly, quantitative real-time PCR (qRT-PCR) was performed on cervical biopsy samples from eligible patients to validate the bioinformatic predictions. Results: The analysis identified 371 common DEGs across datasets, uncovering 102 biological processes, 33 cellular components, 15 molecular functions, 29 significantly enriched pathways, and three key genes. Clinical correlations demonstrated that lesion severity was associated with age, vaginal microbiota composition, and activation of the ALK gene and PI3K/AKT/NF-κB signaling axis. qRT-PCR confirmed increased Discussion: By pinpointing the molecular drivers of disease, this work provides a foundation for interventions aimed at precisely modulating these pathways, improving clinical outcomes and reducing the overall burden of cervical cancer.

Indexed as

ALKcervical precancerous lesionsdiagnosisPI3K/Akt/NF-κBprognosis

Identifiers

PMID40978038
PMCPMC12443549

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.